Erratum to Thrombospondin 1 is a key mediator of transforming growth factor b-mediated cell contractility in systemic sclerosis via a mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK)-dependent mechanism [Fibrogenesis and Tissue Repair, 4 (2011), 9] 10.1186/1755-1536-4-9;Thrombospondin 1 is a key mediator of transforming growth factor β-mediated cell contractility in systemic sclerosis via a mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK)-dependent mechanism

Fibrogenesis and Tissue Repair

Volumn 4, Issue 1, 2011, Pages

  Chen, Yunliang ^a   Leask, Andrew ^b   Abraham, David J ^c   Kennedy, Laura ^b   Shi wen, Xu ^c   Denton, Christopher P ^c   Black, Carol M ^c   Verjee, Liaquat S ^d   Eastwood, Mark ^a  

^a UNIVERSITY OF WESTMINSTER   (United Kingdom)

^b WESTERN UNIVERSITY   (Canada)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79954514135     PISSN: None     EISSN: 17551536     Source Type: Journal    
DOI: 10.1186/s13069-015-0021-1     Document Type: Erratum

References (51)

1. Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 2007, 117:557-567. 10.1172/JCI31139, 1804347, 17332883.
2. Denton CP, Black CM, Abraham DJ. Mechanisms and consequences of fibrosis in systemic sclerosis. Nat Clin Pract Rheumatol 2006, 2:134-144. 10.1038/ncprheum0115, 16932673.
3. Kähäri VM. Activation of dermal connective tissue in scleroderma. Ann Med 1993, 25:511-518.
4. LeRoy C. Increased collagen synthesis by scleroderma skin fibroblasts in vitro. J Clin Invest 1974, 54:880-889. 10.1172/JCI107827, 301627, 4430718.
5. Kähäri VM, Multimäki P, Vuorio E. Elevated pro alpha 2(I) collagen mRNA levels in cultured scleroderma fibroblasts result from an increased transcription rate of the corresponding gene. FEBS Lett 1987, 215:331-334.
6. Abraham DJ, Shiwen X, Black CM, Sa S, Xu Y, Leask A. Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-β in normal and scleroderma fibroblasts. J Biol Chem 2000, 275:15220-15225. 10.1074/jbc.275.20.15220, 10809757.
7. Chen Y, Shi-Wen X, van Beek J, Kennedy L, McLeod M, Renzoni EA, Bou-Gharios G, Wilcox-Adelman S, Goetinck PF, Eastwood M, Black CM, Abraham DJ, Leask A. Matrix contraction by dermal fibroblasts requires transforming growth factor-β/activin-linked kinase 5, heparan sulfate-containing proteoglycans, and MEK/ERK: insights into pathological scarring in chronic fibrotic disease. Am J Pathol 2005, 167:1699-1711. 10.1016/S0002-9440(10)61252-7, 1613194, 16314481.
8. Shi-wen X, Pennington D, Holmes A, Leask A, Bradham D, Beauchamp JR, Fonseca C, du Bois RM, Martin GR, Black CM, Abraham DJ. Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis. Exp Cell Res 2000, 259:213-224. 10.1006/excr.2000.4972, 10942593.
9. Mimura Y, Ihn H, Jinnin M, Asano Y, Yamane K, Tamaki K. Constitutive thrombospondin-1 overexpression contributes to autocrine transforming growth factor-β signalling in cultured scleroderma fibroblasts. Am J Pathol 2005, 166:1451-1463. 10.1016/S0002-9440(10)62362-0, 1606399, 15855645.
10. Chen Y, Shi-wen X, Eastwood M, Black CM, Denton CP, Leask A, Abraham DJ. Contribution of activin receptor-like kinase 5 (transforming growth factor β receptor type I) signaling to the fibrotic phenotype of scleroderma fibroblasts. Arthritis Rheum 2006, 54:1309-1316. 10.1002/art.21725, 16575856.
11. Chen Y, Leask A, Abraham DJ, Pala D, Shiwen X, Khan K, Liu S, Carter DE, Wilcox-Adelman S, Goetinck P, Denton CP, Black CM, Pitsillides AA, Sarraf CE, Eastwood M. Heparan sulfate-dependent ERK activation contributes to the overexpression of fibrotic proteins and enhanced contraction by scleroderma fibroblasts. Arthritis Rheum 2008, 58:577-585. 10.1002/art.23146, 18240216.
12. Leask A, Abraham DJ. TGF-β signalling and the fibrotic response. FASEB J 2004, 18:816-827. 10.1096/fj.03-1273rev, 15117886.
13. Mori T, Kawara S, Shinozaki M, Hayashi N, Kakinuma T, Igarashi A, Takigawa M, Nakanishi T, Takehara K. Role and interaction of connective tissue growth factor with transforming growth factor-β in persistent fibrosis: a mouse fibrosis model. J Cell Physiol 1999, 181:153-159. 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K, 10457363.
14. Bornstein P. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J Cell Biol 1995, 130:503-506. 10.1083/jcb.130.3.503, 2120533, 7542656.
15. Lymn JS, Patel MK, Clunn GF, Rao SJ, Gallagher KL, Hughes AD. Thrombospondin-1 differentially induces chemotaxis and DNA synthesis of human venous smooth muscle cells at the receptor-binding level. J Cell Sci 2002, 115:4353-4360. 10.1242/jcs.00119, 12376566.
16. Esemuede N, Lee T, Pierre-Paul D, Sumpio BE, Gahtan V. The role of thrombospondin-1 in human disease. J Surg Res 2004, 122:135-142. 10.1016/j.jss.2004.05.015, 15522326.
17. Ribeiro SM, Poczatek M, Schultz-Cherry S, Villain M, Murphy-Ullrich JE. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-β. J Biol Chem 1999, 274:13586-13593. 10.1074/jbc.274.19.13586, 10224129.
18. Sakai K, Sumi Y, Muramatsu H, Hata K, Muramatsu T, Ueda M. Thrombospondin-1 promotes fibroblast-mediated collagen gel contraction caused by activation of latent transforming growth factor β-1. J Dermatol Sci 2003, 31:99-109. 10.1016/S0923-1811(02)00150-0, 12670720.
19. Shi-wen X, Pennington D, Holmes A, Leask A, Bradham D, Beauchamp JR, Fonseca C, du Bois RM, Martin GR, Black CM, Abraham DJ. Exp Cell Res 2000, 259:213-224. 10.1006/excr.2000.4972, 10942593.
20. Abraham DJ, Shiwen X, Black CM, Sa S, Xu Y, Leask A. Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-β in normal and scleroderma fibroblasts. J Biol Chem 2000, 275:15220-15225. 10.1074/jbc.275.20.15220, 10809757.
21. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Rowell N, Wollheim F. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988, 15:202-205.
22. Shi-wen X, Stanton LA, Kennedy L, Pala D, Chen Y, Howat SL, Renzoni EA, Carter DE, Bou-Gharios G, Stratton RJ, Pearson JD, Beier F, Lyons KM, Black CM, Abraham DJ, Leask A. CCN2 is necessary for adhesive responses to transforming growth factor-β1 in embryonic fibroblasts. J Biol Chem 2006, 281:10715-10726. 10.1074/jbc.M511343200, 16484225.
23. Eastwood M, Porter R, Khan U, McGrouther G, Brown R. Quantitative analysis of collagen gel contractile forces generated by dermal fibroblasts and the relationship to cell morphology. J Cell Physiol 1996, 166:33-42. 10.1002/(SICI)1097-4652(199601)166:1<33::AID-JCP4>3.0.CO;2-H, 8557773.
24. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002, 3:349-363. 10.1038/nrm809, 11988769.
25. Eastwood M, McGrouther DA, Brown RA. A culture force monitor for measurement of contraction forces generated in human dermal fibroblast cultures: evidence for cell-matrix mechanical signalling. Biochim Biophys Acta 1994, 1201:186-192.
26. Eastwood M, Mudera VC, McGrouther DA, Brown RA. Effect of precise mechanical loading on fibroblast populated collagen lattices: morphological changes. Cell Motil Cytoskeleton 1998, 40:13-21. 10.1002/(SICI)1097-0169(1998)40:1<13::AID-CM2>3.0.CO;2-G, 9605968.
27. Meek RL, Cooney SK, Flynn SD, Chouinard RF, Poczatek MH, Murphy-Ullrich JE, Tuttle KR. Amino acids induce indicators of response to injury in glomerular mesangial cells. Am J Physiol Renal Physiol 2003, 285:F79-86.
28. Grinnell F. Fibroblast biology in three-dimensional collagen matrices. Trends Cell Biol 2003, 13:264-269. 10.1016/S0962-8924(03)00057-6, 12742170.
29. Skalli O, Gabbiani G. The biology of the myofibroblast in relationship to wound contraction and fibrocontractive disease. The Molecular and Cellular Basis of Wound Repair 1998, 373-402. New York: Plenum Press, Clark RAF, Henson PM, 2.
30. Rudolph R, Van de Berg J, Ehrlich PH. Wound contraction and scar contracture. Wound Healing, Biochemical and Clinical Aspects 1992, 96-114. Philadelphia, PA: Saunders, Cohen IK, Diegelmann RF, Lindblad WJ.
31. Agah A, Kyriakides TR, Lawler J, Bornstein P. The lack of thrombospondin-1 (TSP1) dictates the course of wound healing in double-TSP1/TSP2-null mice. Am J Pathol 2002, 161:831-839. 10.1016/S0002-9440(10)64243-5, 1867266, 12213711.
32. Robbins JR, Evanko SP, Vogel KG. Mechanical loading and TGF-β regulate proteoglycan synthesis in tendon. Arch Biochem Biophys 1997, 342:203-211. 10.1006/abbi.1997.0102, 9186480.
33. Carlson MA, Longaker MT. The fibroblast-populated collagen matrix as a model of wound healing: a review of the evidence. Wound Repair Regen 2004, 12:134-147. 10.1111/j.1067-1927.2004.012208.x, 15086764.
34. Grinnell F. Fibroblast-collagen-matrix contraction: growth-factor signalling and mechanical loading. Trends Cell Biol 2000, 10:362-365. 10.1016/S0962-8924(00)01802-X, 10932093.
35. Prajapati RT, Chavally-Mis B, Herbage D, Eastwood M, Brown RA. Mechanical loading regulates protease production by fibroblasts in three-dimensional collagen substrates. Wound Repair Regen 2000, 8:226-237. 10.1046/j.1524-475x.2000.00226.x, 10886813.
36. Azuma A, Li YJ, Abe S, Usuki J, Matsuda K, Henmi S, Miyauchi Y, Ueda K, Izawa A, Sone S, Hashimoto S, Kudoh S. Interferon-β inhibits bleomycin-induced lung fibrosis by decreasing transforming growth factor-β and thrombospondin. Am J Respir Cell Mol Biol 2005, 32:93-98. 10.1165/rcmb.2003-0374OC, 15557019.
37. Pierce GF, Mustoe TA, Lingelbach J, Masakowski VR, Griffin GL, Senior RM, Deuel TF. Platelet-derived growth factor and transforming growth factor-β enhance tissue repair activities by unique mechanisms. J Cell Biol 1989, 109:429-440. 10.1083/jcb.109.1.429, 2115493, 2745556.
38. Krishnaswami S, Ly QP, Rothman VL, Tuszynski GP. Thrombospondin-1 promotes proliferative healing through stabilization of PDGF. J Surg Res 2002, 107:124-130.
39. Zhang ZG, Bothe I, Hirche F, Zweers M, Gullberg D, Pfitzer G, Krieg T, Eckes B, Aumailley M. Interactions of primary fibroblasts and keratinocytes with extracellular matrix proteins: contribution of α2β1 integrin. J Cell Sci 2006, 119:1886-1895. 10.1242/jcs.02921, 16636073.
40. de Rooij J, Kerstens A, Danuser G, Schwartz MA, Waterman-Storer CM. Integrin-dependent actomyosin contraction regulates epithelial cell scattering. J Cell Biol 2005, 171:153-164. 10.1083/jcb.200506152, 2171213, 16216928.
41. Leask A. Scar wars: is TGFβ the phantom menace in scleroderma?. Arthritis Res Ther 2006, 8:213. 10.1186/ar1976, 1779423, 16774692.
42. Nakagawa T, Lan HY, Glushakova O, Zhu HJ, Kang DH, Schreiner GF, Böttinger EP, Johnson RJ, Sautin YY. Role of ERK1/2 and p38 mitogen-activated protein kinases in the regulation of thrombospondin-1 by TGF-β1 in rat proximal tubular cells and mouse fibroblasts. J Am Soc Nephrol 2005, 16:899-904. 10.1681/ASN.2004080689, 15716330.
43. Wilson KE, Li Z, Kara M, Gardner KL, Roberts DD. Beta 1 integrin- and proteoglycan-mediated stimulation of T lymphoma cell adhesion and mitogen-activated protein kinase signaling by thrombospondin-1 and thrombospondin-1 peptides. J Immunol 1999, 163:3621-3628.
44. Frazier KS, Grotendorst GR. Expression of connective tissue growth factor mRNA in the fibrous stroma of mammary tumors. Int J Biochem Cell Biol 1997, 29:153-161. 10.1016/S1357-2725(96)00127-6, 9076950.
45. Fears CY, Woods A. The role of syndecans in disease and wound healing. Matrix Biol 2006, 25:443-456. 10.1016/j.matbio.2006.07.003, 16934444.
46. Chen Y, Abraham DJ, Shi-Wen X, Pearson JD, Black CM, Lyons KM, Leask A. CCN2 (connective tissue growth factor) promotes fibroblast adhesion to fibronectin. Mol Biol Cell 2004, 15:5635-5646. 10.1091/mbc.E04-06-0490, 532042, 15371538.
47. Kennedy L, Liu S, Shi-Wen X, Chen Y, Eastwood M, Sabetkar M, Carter DE, Lyons KM, Black CM, Abraham DJ, Leask A. CCN2 is necessary for the function of mouse embryonic fibroblasts. Exp Cell Res 2007, 313:952-964. 10.1016/j.yexcr.2006.12.006, 17239853.
48. Chen Y, Blom IE, Sa S, Goldschmeding R, Abraham DJ, Leask A. CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC. Kidney Int 2002, 62:1149-1159. 10.1111/j.1523-1755.2002.kid567.x, 12234285.
49. Stratton R, Rajkumar V, Ponticos M, Nichols B, Shiwen X, Black CM, Abraham DJ, Leask A. Prostacyclin derivatives prevent the fibrotic response to TGF-β by inhibiting the Ras/MEK/ERK pathway. FASEB J 2002, 16:1949-1951.
50. Bornstein P, Agah A, Kyriakides TR. The role of thrombospondins 1 and 2 in the regulation of cell-matrix interactions, collagen fibril formation, and the response to injury. Int J Biochem Cell Biol 2004, 36:1115-1125. 10.1016/j.biocel.2004.01.012, 15094126.
51. Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J, Hynes RO, Boivin GP, Bouck N. Thrombospondin-1 is a major activator of TGF-β1 in vivo. Cell 1998, 93:1159-1170. 10.1016/S0092-8674(00)81460-9, 9657149.